{"name":"Vigeo Therapeutics, Inc.","slug":"vigeo-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9IdmpZWFNfT0Nza2pqNjZXbDVMOHZrSjRWUVpCRVdvMUpGTW8ybnpnN05vc0pRZzN4X0lsaHFHSHBPVml1WWZuT2dKNkpucVB5ZVNTS0dHdFZnTzVPcER0SUJ6MjNHd0RTZzhJcXdLWnFVMnZmaUNHTW9pRQ?oc=5","date":"2025-01-03","type":"regulatory","source":"Wiley","summary":"A trial of radiolabeled antibody yttrium-90–FF-21101 for the treatment of advanced ovarian and other cancers - Wiley","headline":"A trial of radiolabeled antibody yttrium-90–FF-21101 for the treatment of advanced ovarian and other cancers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}